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Abstract. The objective of this paper is to give a review of the main works dealing with
mathematical modeling of blood cell formation, disorders and treatments within the past fifty
years. From the first models to the most recent ones, this research field has inspired many leading
experts in mathematics, biology, physics, physiology and computer sciences. Each contribution
was a step further to the understanding of these complex processes. This work summarizes the
key ones and tries to show not only the evolution of the interest for this problem but also the
different research trends throughout the decades up to the latest models of the past years.
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1. Introduction
The aim of this work is to give an overview of the main mathematical models related to blood formation
(also called hematopoiesis), disorders and treatments. Thousands of papers have been investigating this
topic in the past half century leading to many progresses in the development of mathematical analysis
tools, numerical simulations, strategies to estimate parameters and forecast optimal treatments to specific
diseases.
Describing all of them in detail would take at least a whole book and certainly several volumes. Our
attempt here is to set up what we consider as key contributions to this field and we apologize in advance
for the numerous high quality researchers that we do not mention here. Our selection is purely subjective
and based on two different criteria:
1. paper introducing the first models of their kind, like for instance the first equations describing cell
cycles,
2. the most interesting and impacting results bringing contribution both to the mathematical and bio-
logical communities.
Thanks to the development of new techniques both in biology and mathematics, this topic has con-
stantly been evolving throughout decades and the different step forward in the understanding of com-
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plex processes needed scientists to continuously adapt their hypotheses. For instance, some speculative
modeling assumptions supposed to be holding in the past, were proven to be wrong by biological new
experimental protocols (a famous example is the discovery of the role of erythropoietin (EPO), proven to
act on cell apoptosis only in the early 1990’s). On the other hand, the knowledge of blood cell formation
processes have reached such high levels of complexity that it progressively appeared extremely important
and helpful to strengthen the already existing collaborations between leading experts in mathematics,
biology, physiology, physics and computer sciences altogether.
This is somehow the story that we try to tell here.
But, before starting our journey through more than fifty years of mathematical modeling, it seems
important to briefly remind the basics of hematopoiesis.
1.1. Hematopoiesis: brief biological background
As it is well described in any biological textbook (see for instance [157]), hematopoiesis deals with
formation and regulation of blood cells in the body. It all starts in the developing embryo. Blood cells
of the early stages are located in the yold sacs also called blood islands. They move then to the spleen,
liver and lymph nodes. After birth, they are formed only in the bone marrow mostly in vertebra, pelvis
and sternum.
We are only interested in postnatal hematopoiesis since it is related to most of the different pathologies,
treatments and description in the literature. Prenatal hematopoiesis is left to other reviews.
In postnatal ages, blood cells always follow the same pattern:
1. they all originate from the same source known as hematopoietic stem cells (HSC). These cells are able
to self-renew. They are quite powerful in the sense that only a few of them can repopulate the whole
bone marrow after a bone transplant. We shall show that this property is of great importance in the
mathematical modeling of hematological disorders.
It is interesting to point here the fact that even if embryonic stem cells have been suggested to exist
in 1908 by Maximov [208] (who was the first one to call them this way), evidence of existence of stem
cells in the bone marrow was only proven in 1963 by McCulloch and Till [50]. Fifteen years later, in
1978, HSC were found in the blood of the umbilical cord [229]. And we had to wait until 1997 to get
a link between leukemia and hematopoietic stem cells showing the first cases of cancer stem cells [66].
2. From HSC, two main cell lineages appear: myeloid and lymphoid. Cells in the lymphoid lineage will
give birth to immune cells such as: T-cells, antibody and memory cells. As proliferation, activation
and regulation of these cells are located mostly in the lymphoid organs and not the bone marrow, its
description is more adapted to immunology theory than hematopoiesis. This is the reason why we do
not want to describe the lymphoid branch further here but only cells in the myeloid lineage.
Immature myeloid cells have three possible fates: either becoming a red blood cell, a platelet or a
white blood cell.
3. Each lineage is regulated by several growth stimulating factors, essentially hormones. Each one of the
three lineages has one leading hormone: erythropoietin (EPO) for red blood cells (found in 1906 by
Carnot and Deflandre [75]), thrombopoietin (TPO) for platelets (discovered in 1958 by Kelemen et al.
[165]), and granulocyte colony stimulating factor (G-CSF) for white blood cells (discovered in 1985 by
Metcalf [209]). Regulation of production of blood cells is highly complex and considering all the actors
of this mechanisms is a real challenge. Thus, control systems need to be considered with extreme care
when simplified in the mathematical models.
4. Each cell has its own life: during its cycle a new born cell need to go through different phases called
G1, S, G2, M and G0. The first four phases describe the proliferating phase while the last one stands
for the resting phase. During its life, a cell has three main choices: either die by apoptosis (natural
cell death) anytime in its cycle or split into two daughter cells at the end of its proliferating phase. If
at least one of the daughter cells can be identical to mother cells we face what is called a self-renewing
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process, and if both daughter cells are different from their mother, we call it differentiation. Self-
renewal is often considered for stem cells or progenitor cells. After division, most of normal blood cells
reach the G0 phase which is not the case for cancer cells who in general keep dividing without resting.
1.2. Modeling strategies throughout decades: different trends
Since hematopoiesis is a highly complex process, different strategies have been elaborated throughout
the years to get the most appropriate answers to some specific given problems. The common point to
all of them has been to remain as simple as possible in order to focus on mainly one objective, like, for
instance red blood cell formation only, or impact of cycle disorders to different pathology such as anemia
or leukemia, or optimal therapeutic strategies for specific treatments about blood diseases.
Then, mathematical modeling took different aspects depending on the targeted problem. It could have
been deterministic only when a large amount of cells is observed, with or without diffusion depending on
whether space or not is considered. There would have been some feedback at different level if necessary.
Stochastic processes may have been inserted in the model if the number of cell population was not large
enough or if some event could be highly unpredictable. Multiscale modeling could have been chosen when
interaction at different levels (molecular, cell, and organ levels for instance) is investigated. Some delays
in reactions may have been put in equations when necessary and eventually only numerical simulations
have been developed when the models were too complicated to analyze theoretically. Individual based
models (IBM) also called agent based models (ABM) and multi-agent systems have then been introduced
to handle some of these complex models.
Each decade had followed different modeling trends. Some of them remained highly active throughout
several decades while others seemed to have left this field for others.
The main question we shall try to answer in this paper is the following: do mathematical models
applied to blood cell formation tend to behave like the cells they try to describe? In other words, do they
die by natural death, do they self-renew somehow throughout decades or to they differentiate to more
“mature” models?
In order to answer this question, we give the most representative models of each decades and try to see
if they were trends only for a couple of years, whether they were rich enough to survive through years,
or if they evolved to something more elaborated or at least different.
Each section will be dedicated to one decade, starting with the 1960’s. There will be thus 5 sections
for 50 years of blood cell dynamics studies. These sections will not be well balanced, in the sense that
early years were not as prolific as the last ones. However, we will try to be as synthetic as possible and
as fair as possible to depict these half of a century’s journey in this incredibly rich research field.
2. The 1960’s: early models
Up to the early 1960’s, many publications had already provided quantitative data about blood cells
in the bone marrow (like Hulse [161] for instance). But to the best of our knowledge, no one, at that
time had ever proposed a mathematical model to attempt to describe their complex dynamics, until 1963
where the first ones started to emerge [271]. Amongst the earliest papers, the trend seemed to be focused
on iron kinetics in the red blood cell population [221]. These models where already quite complex. In
[221] for instance, the authors decided to use a compartmental model (see Fig. 1) and distributed delay
equations. At that times, mathematical tools to obtain an analytical work out of these equations were
not developed yet, and so, only numerical works could be done. Furthermore, although iron oriented
only, these models are quite interesting because they already get the spirit of how mathematical models
should be built to describe biological phenomena. Let us quote for instance one of the first papers on
this field :
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1. “Approximating equations to the experimental data should be as simple as possible. They should not
contain a priori terms which are not capable of detection or whose contributions fall within the limits
of experimental errors.
2. The approximating equations should lend themselves to interpretations as solutions for the behavior
of mathematical models which represent an“idealization” of the metabolic processes considered. These
should not contradict the accepted basic concepts of physiology.
3. Such model should elucidate metabolic processes beyond the mere numerical representations of the
experimentally available data ,”
taken from the introduction of [271].
These precepts have been followed in almost every point. Indeed, some of the models after this wanted
to take some terms that where not possible to measure experimentally but whose existence were at least
suggested by experimental evidence.
Figure 1. “Iron compartmentation and kinetics” from the Nooney model [221].
At the same time a stochastic approach was first introduced in 1963 by Till et al. [282] to describe
stem cell proliferation based on the growth of spleen colony forming cells. Even if not focused on the
bone marrow, this work was interesting in the sense that it rose some of the most important questions
of feedback controls. Moreover, we should point out that this model was built at the exact same time of
the discovery of existence of stem cells in the bone marrow [50].
It seems that, in the early 1960’s, some scientists started to perceive the importance of the mathematical
modeling of blood cell kinetics, to support the most recent biologist’s discoveries of that period. We get
the feeling that this was the starting point of the development of this branch of mathematics applied to
biology, even if, we can express a slight concern about this:most of scientists (if not all of them) developing
these models back then, were not mathematician but physicist, chemists, biologists or clinicians. We
would have to wait until the end of next decade to notice some first timid steps of mathematicians in
this field.
Let us finish the 1960’s by the work of Kirk et al. in [167] where oscillation as well as interactions and
control mechanisms of the red blood cell and bone marrow stem cell were studied. The mathematical
model consisted in four difference-differential equation and studied numerically (see Fig. 2). This paper
was the start of a long series of mathematical work developing models to describe periodic oscillating
blood diseases.
As seen in this section, the 1960’s witnessed the first timid attempts of mathematical models about
blood cell dynamics without any contributions of mathematicians. The following decade was about to
reveal a clear desire to go further.
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Figure 2. Representation of the red and stem cell system from Kirk et al. [167].
3. The 1970’s: the rise of mathematicians’ interests
This decade started quite early in September 1970 when Burns and Tannock [73] proposed for the
first time a model of cell cycle including a resting phase also called G0 phase. At that time, existence
of the G0 phase had recently been admitted. It started indeed with the work of Quastler and Sherman
in 1959 [233], the same Quastler, who four years later, in 1963 named, this phase G0 in [232]. This new
phase took less than a decade to be well accepted by the biologist community and, thanks to Burns and
Tannock, this phase appeared shortly after in a mathematical model (see Fig. 3). Even if this model was
not designed for hematopoiesis, but for rat dorsal epidermis cells, it has become the inspiring starting
point of a long series of models describing blood cell cycles in the bone marrow. It is interesting to note
also that this model included cell labeling (with 3H-thymidine in this case) in its equations, and this
idea of including cell markers as variables of the model is still currently used. This paper was followed
3 years after by the work of Smith and Martin [273], whose model, even if focused on the dynamics of
cells of any kind became also a reference for modelers in hematopoiesis. In this paper, also dealing with
3H-thymidine labeling, the authors made a short reference to the Burns and Tannock model “formally
identical” to theirs, adding that in 1970, Burns and Tannock “failed to generalize their model, applying
it only to slowly proliferating cells. Neither did they adduce firm evidence in its favor, and their paper
has not received the attention it deserves, even in the restricted field to which it was applied”. We can
note that Smith and Martin called the resting phase, the A-state instead of the G0 phase. Moreover,
their model consisted in several differential linear equation which was a rather different approach from
the Burns and Tannock’s work.
It is interesting to make a short remark here: in following decades, to the best of our knowledge, when
dealing with cell cycle deterministic models with a resting phase, most of mathematicians were inspired
by Burns and Tannock, while biologists and physicists preferred the Smith and Martin one.
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Figure 3. Diagram representing the Burns and Tannock G0 model [73].
Let us go back to hematopoiesis. Amongst more than 200 models published in this field during the
1970’s (granulopoiesis, control of erythropoiesis, anemia, stem cells, leukemia), several of them caught
our attention for different reasons exposed below.
The same year as Burns and Tannock’s model, King-Smith and Morley published a work [166] in which
they considered the problem of cyclical neutropenia (CN), a blood disease involving a part of the myeloid
branch that produces neutrophils. In this work, authors wanted to show that, this disorder was due to
a loss of stability in the peripheral control process regulating neutrophil production through a negative
feedback between mature neutrophils and their precursors. Based on the Kirk et al. [167] approach, this
mathematical model here was more computer oriented, but it was one of the first models dealing with
a periodic chronic blood disease with oscillations due to the loss of stability. No mathematical analysis
was done in this work but it inspired several authors, like Kazarinoff and van den Driessche in [164], nine
years later, and many investigations of chronic blood diseases through Hopf bifurcation would follow in
the next decades, becoming one of the modeling trends of that period.
On the same spirit as the Burns-Tannock and Smith-Martin work on trying to describe cell dynamics
and estimate parameters with labeling markers, Rubinow and Lebowitz, published a paper in 1975 [253].
The authors introduced the first age-maturity model applied to hematopoiesis (myeloblast cells in this
case). They were inspired by the work of Von Foerster [285] who described the kinetics of cellular
proliferation with structured partial differential equations but not applied to hematopoiesis. Rubinow
and Lebowitz had been working on this problem for more than 6 years before releasing their results about
blood cells in the 1975’s paper. In 1968, Rubinow, for instance had described a maturity structured model
arising from Tetrahymena Gelei human cell cycle. One of the important new feature in this work was
the concept of “maturation velocity” [252].
Another turning point during these years were the release of two papers, one in 1976 by Lasota and
Waz˙ewska-Czyz˙ewska [175] and the other one in 1977 by Mackey and Glass [198]. Without knowing each
other at that time, these authors published almost simultaneously two models very similar in several
points: both were arising from red blood cell development (the one from Lasota and Waz˙ewska, see Eq.
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(3.1)),
dx(t)
dt
= −γx(t) + βe−αx(t−τ), (3.1)
the other, known now as the Mackey-Glass equation, arose from white blood cell production to study
a periodic form of chronic myelogenous leukemia (see Eq. (3.2)). Both of them were delay differential
equations.
dx(t)
dt
= −γx(t) + β x(t− τ)
1 + x(t− τ)n . (3.2)
Slight changes made the difference: the Lasota -Waz˙ewska model was derived from an age structured
partial differential equation, and delay was a consequence of its integration, and on the other hand, the
Mackey-Glass equation had been set up directly into a delay differential equation. The non-monotone
nature of the nonlinearity of this latter brought a much richer behavior than the derived differential
equation. Both approaches remain milestones in the sense that they are still used as references for new
mathematical models and the development of delay differential equations. By coincidence Waz˙ewska-
Czyz˙ewska, Lasota and Mackey met for first time in 1977 just right after having published their work
respectively. Another coincidence is that in a third place in the world, another team consisting of Perez,
Malta, and Coutinho came out with the same kind of delay differential equation but the model was built
to study oscillation of the fly populations [226] (see Eq. 3.3).
dx(t)
dt
= −γx(t) + (β0 − β1x(t− τ))x(t− τ). (3.3)
The end of the 1970’s was then an important period in the sense that many mathematicians like
Rubinow, Mackey, Lasota, van den Driessche and others started to be interested in the modeling of
problems arising from hematological issues. And even if they appeared earlier in the 1960’s, delay
differential equations as well as structured partial differential equations started to be developed and
analyzed by mathematicians with the objective to get a better understanding of the hematopoiesis process.
It is important to point out that, from the last years of this decade, the study of delay differential equations
became a clearly emerging trend. And even at this precise moment where this present paper is written,
this trend is still ongoing and it is in great shape.
The 1980’s would then surf on this young wave that had started a couple of years before.
4. The 1980’s: mathematicians are in the place
As mentioned in the introduction, after erythropoietin (EPO) for red blood cells (1906), and throm-
bopoietin (TPO) for platelets (1958), the last important group of stimulating hormones, involving leuko-
cytes, was discovered in 1985 [209]. It seemed natural then to see this white blood cells stimulating factor,
called G-CSF for granulocyte colony stimulating factor, introduced by mathematicians in their models in
the second part of this decade (4).
It is interesting to note that, after the 1970’s and the rise of mathematician interest in blood cell
dynamics, a large number of important hematological discoveries were “fairly” rapidly (less than 10
years) integrated into new mathematical models but not as fast as expected in the beginning (more than
five years in average after the first three decades after the 1970’s) (see the example of Mackey and Do¨rmer
below for instance). However, this delay has been shortened after the years 2000, as collaboration between
mathematicians and biologists became much stronger.
But let us come back to the early 1980’s. This period, in the exact continuity of the end of the
1970’s, paved the way to small groups of young mathematicians who showed new modeling perspectives,
developed new mathematical tools and had a great impact both in mathematics and biology.
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Figure 4. Illustration of blood regulation system in the bone marrow, with the main
stimulating growth factors (EPO, TPO and G-CSF).
In 1980, Lasota and Mackey strengthened their collaboration and investigated mathematically the
model of their common interest in [172] with applications to chronic myelogenous leukemia and repeated
it in 1981 [173] and in 1984 [174] for the main work applied in hematopoiesis. Mackey developed his
work with other collaborators such as Do¨rmer on erythropoiesis [197], [199] where they studied an age
and maturity structured model to be more consistent with experimental data claiming that “proliferating
hematopoietic precursor cells may pass between morphological compartments at any point in the cell cycle”
and their age-maturity model seemed to be a good approach to describe this mechanism. This work
originated from the observation that their available hematopoietic data were inconsistent with some of
the previous theoretical work achieved in the 1970’s by Rubinow and Lebowitz [253]. And thus, this “old”
model where cells were supposed to differentiate (increase maturation) right after cytokinesis needed to
be adapted to this new biological hypothesis.
Mackey’s prolific collaboration in hematopoiesis modeling followed with An der Heiden and Milton
on dynamical diseases and bifurcations in physiological disorders in general and the so called periodic
hematopoiesis in particular [195], [34], [217], investigated more in details in the next decades under the
forms of cyclical neutropenia, periodic chronic myelogenous leukemia, and cyclical thrombocytopenia.
Problem arising from platelet production was the object of a joint work with Be´lair at the end of the
decade [53] and has been the starting point of a long collaboration in hematopoiesis modeling.
On the other hand, a young group of mathematicians started to emerge also in this field during these
years. With a long list of papers on cell cycle they introduced and explored new techniques to analyze
some of the past models but also new ones. While the Mackey group was mostly focused on oscillating
dynamics and periodic hematological diseases, this group was mostly concentrated on mathematical
analysis of structured models, with different structures such as age [286], size [105], [145], as well as
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a mix ot them like age-size [146], [95] and considering equal or unequal division [144], [39]. Some of
these models were coming in direct line from the 1970’s models or the early 1980’s as presented above.
But the objectives of these mathematicians was to set up the rigorous mathematical frameworks of the
partial differential equations involved (mostly hyperbolic equations of transport type) defining the most
appropriate functional spaces to study solutions. They were mainly focused on existence, uniqueness,
positivity of the problems as well as stability analysis and asynchronous exponential growth (that is
the asymptotically exponential growth of a population with a steady distribution with respect to the
structure variables and irrespective of the initial condition) [287], [143] using different tools such as semi-
group theory[288], [210], [37], [38] for instance. More theoretical than experimentally oriented, these
works could be adapted to many different cell cycle problems and not only to hematopoiesis. But they
set up the bases of many models and techniques used in the next decades to solve blood cell formation
problems.
Finally, and to the best of our knowledge a third group specialist started to emerge. Also interested in
cell proliferation modeling, this group, mainly composed of Wichmann and Loeﬄer as a base, started to
publish their first work about hematopoietic stem cell proliferation in 1980 [185]. Consisting of a system
of delayed differential equations, the model is mostly studied numerically and compared with erythroid
progenitors experimental data. Their collaboration continued throughout the decade. After a study on
the probability of self-renewal hematopoietic stem cells [295], they came back with a more complex system
of differential equations, with no delay, to describe the kinetics of hematopoietic stem cells during and
after hypoxia [186]. Still dealing with differential equations, they focused their attention on granulopoiesis
[235], [296]. In 1988, they summarized their research work on hematopoiesis in four hypothesis [297]. The
next year, they released several works: the first one split into two about the study of hematopoiesis under
thiamphenicol treatment [141], [187], and the second into four parts to describe stress erythropoiesis in
mice and rats [188], [298], [300] (the fourth part was published in 1990 [225]). Equations of these models
were composed of systems of differential equations and based on previous models of the late 1960’s, the
1970’s and the 1980’s from Tarbutt and Blakett 1968, Mylrea and Abbrecht (1971), Aarneas (1978), Mary
et al. (1980), Leonard et al. (1980), Pabst et al. (1981, 1985) (full references can be found in [188] for
instance).
This third group, consisting of clinicians, biologists and biomathematicians, mostly interested by con-
sistency with experimental data and parameter estimates was closer to the Mackey’s group spirit than the
mathematician young group. The objective of this latter was more theoretically oriented with challenges
in developing new mathematical tools and analysis techniques to investigate partial differential equations.
Many other groups studied hematopoiesis problem in different forms (as we mentioned few of them above),
but these three groups where certainly the most impacting of the 1980s.
Several themes were highlighted by these groups: cyclical diseases, stem cell study, hematopoiesis under
treatment, feedback control due to stimulating hormones for the biologist side, and study of systems
of differential equations with or without delays, analytic studies of steady states, stability, oscillating
behavior, and partial differential equations of transport type with some study of asynchronous exponential
growth, and semi-group analysis.
These groups planted the seeds for the development of this branch of mathematics applied to biology.
And this seeding appeared to be quite successful since it grew bigger in the following decades.
5. The 1990’s: continuity
During the 1990s, the three 1980’s groups kept on working on their themes, and some new center
of interest started to rise. Let us summarize it in this section. Strong collaborations kept on being
fruitful. For instance, Mackey produced several works mostly theoretical with Lasota [176], [177] on
stability studies for cell replication, work with Milton [200] on feedbacks and delays, Be´lair and Mahaffy
on two delay models [54] and state dependent delay models with moving boundary contitions [204]. New
collaborations started on the same spirit as Lasota, mainly with Rudnicki [202], [203] on theoretical study
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of an age-maturity model. New fields were investigated also like chaos of hematopoietic cell population
with Crabb et al. [93]. Note that this theme started to be trendy during this period for hematopoiesis
modeling since it was also studied by Webb and collaborators from an analytical point of view: through
instability of solutions and hypercyclicity [104], [117], [118], [119], [120]. Some review papers about
models of hematopoietic cell replication and control were published to set up a state of the art after three
decades of work on this field [42], [193], [44], [152].
One of the most trendy work at this period was leukopoiesis (white blood cell formation) and its related
pathologies. Many papers from the Mackey’s group as well as the Loeﬄer’s group were published in this
field. Most of these works were concerned on mathematical modeling of course, but most importantly on
comparison between numerical stimulation and experimental data. This makes sense in regards of what
has been said in the previous section about biological discoveries included in models. The granulocyte
colony stimulating factor (G-CSF) was discovered in 1985 by Metcalf [209], and started to be intensively
studied in mathematical models in the 1990’s both by Loeﬄer and his group starting in 1990 [72], theen
in the mid 1990’s [220], [97], [99], [100], [266] and late 1990’s in [239]. Mackey worked on it only in the
late 1990’s [153], [155]. Two pathologies rose the attention of these two groups: chronic myelogenous
leukemia in its periodic form [133] and [283], [192], both in the late 1990’s, and cyclic neutropenia,
starting in the middle of the 1990’s too for Loeﬄer [265] and late 1990’s for Mackey [156]. Other general
cyclic hematopoietic diseases were studied [264], some with chemotherapy modeling attempts [270], [163]
or treatments [142] and other hematotoxic products [260]. Few works were focused on erythropoiesis,
besides some theoretical approaches from Be´lair et al. [54], [202], [254], [256] and some attempts to fit
experimental data for anemia [189], or erythropoietin (EPO) effect [98], [101].
Let us come back a few moment here to the short example given in the introduction (section 1))
about EPO. Let us point out two things here: first even if the action of EPO on red blood cell apoptosis
regulation in the bone marrow had been discovered in 1990 [170], nobody to our knowledge clearly
included this discovery in their models during this decade. It would appear only in some of the models
of the late 2000’s. On the other hand, megacaryopoiesis was not of great interest at that time, and very
few models appeared in this field [125].
It is interesting also to note that the big rise of interest from the “young” mathematician group slightly
faded out. Nevertheless, there were still few results on asynchronous exponential growth [147], [289], [290],
[45] some on semi-group analysis [258], some with existence and uniqueness results [69], slow oscillation
evidences [41], models with unequal division and random transition [40] and emergence of a new interest
of aging cells with telomere loss [43], [46].
A little bit like a souﬄe´, interest of mathematicians on this topic started to fade out as their exploring
ideas tended to lead them to some other theoretical work, tools and models. The big “hits” of this decade
were certainly leukopoiesis analysis, G-CSF stimulating factors and chaos.
However, the years 2000’s gave birth to the new generations taking over certain research fields from
their mentors, and new increase of interest rose at the dawn of the new coming century. New biological
discoveries, new techniques to obtain experimental data and new collaborations between generations of
scientist were about to give new ways of tackling these problems.
6. The 2000’s: from one generation to another
The years 2000’s witnessed the rise of the second generation of mathematicians involved in bone marrow
blood cells modeling. Some works followed the guided path of the first generation while new ideas, new
themes and new tools started to be explored.
For the models and theory initiated in the previous decades, it was interesting to notice that asymptotic
exponential growth applied to blood problems was not trendy any more, and to the best of our knowledge
no work was developed besides [123]. Quite popular in the 1980’s, this property may come back on the
foreground in the next decades for new hematological equations.
101
“PUJO-REVIEW-v1” — 2016/2/7 — 20:13 — page 102 — #11i
i
i
i
i
i
i
i
L. Pujo-Menjouet Blood cell dynamics: half of a century of modelling
Theoretical evidence of chaos also, a notion that was believed to be promising in the past decade
never really took off besides some rare publications on with hypercyclicity in particular [122] and chaos
applied to cell cycle in general [124], [255]. Some mathematical tools were developed through theoretical
work on the model, specially to study locally or globally asymptotic solutions [9], [10], [22], [87], [12]
and bifurcation analysis (mostly Hopf bifurcation leading to oscillation of cell population) [92], [58] [280],
[85] for structured partial differential equations (mostly age-structured, but also maturity or age and
maturity, or age and cyclin structured...)[79], [51], [51], [121], [29], and differential equations with delays
(sometimes discrete, or distributed or state dependent) [56] [30], [31] or impulsions [169].
The main goal for these models was essentially the mathematical development of theoretical tools to
develop the problems. They were, for a majority, not quantitatively applied to the biological problems,
but qualitatively oriented.
Most of the models were issued from the past decades and slightly generalized for a technical mathe-
matical development.
New approaches started to emerge and developed with a huge technical progress in computer abilities:
agent based models or individual based models or multi-agent models [248], [268], [63], [65], [135], [109].
Consisting of a mix of deterministic equations and stochasticity and a lot of computer programming,
these new models were aimed at describing either a cell motion, its interactions with the inner and outer
cellular environment, or interactions of a group of cells in the bone marrow. They were not totally new
from a theoretical point of view, but their applications to hematopoiesis started to rise a great interest
from the biological and clinical community. It was possible for once to see almost on live, in silico cells
moving and interacting on a motion picture. This novelty managed to illustrate the complex equations
used by mathematicians in order to point out the biologist issues and work in a closer cooperation. This
field became an excellent way to initiate or to strengthen collaboration between each disciplines, which
was and still is one of the most difficult challenges in this area.
The main difficulty for this approach is more technical than theoretical. Once models are set up
with biologist and clinician advise, the computer needs to compute tenth, hundreds or thousands cells
interacting with each other, getting informations from their environment, dealing with these informations
by intra cellular reactions at molecular levels, and providing a decision to communicate to the external
environment with other cells: does the cell divide? Does it choose to become a platelet, a red cell, a
white cell? And many other decisions. This means hundreds of computations per cell, which leads to
a tremendous amount of computations for hundreds of cells interacting. Computers need to be really
powerful to handle this. It started to be the case early in the 2000’s and keep on being possible with the
increase of computer power abilities and decrease of their production price. Development of this branch
is then link with the development of technologies, but first results have been really promising.
As mentioned above, this new trend was also coupled with a more frequent introduction of stochasticity
in the deterministic models, and specially in the lineage choice, one of the very difficult problems in this
decade, and still is in the beginning of the 2010’s. Does a cell decide its fate? Does it come from the
inside or the outside of the cells, the interactions between other cells or growth hormones influence, or
simply a mix of everything creating the medullar environment. If the cell decides its fate, what are the
interactions involved. Many attempts consist of tens or hundreds of differential equations. We do not
talk about these ones, way too complex to get either an analytic work out of it, but also to investigate
the influence of specific parameters. Stochasticity and deterministic approaches were amongst the most
appropriate answers to the modeling challenges and started to be popular in the scientific community
dealing with lineage choice or cell fate [137], [242], [246], [160].
Let us mention now, two of the largest fields investigated by the modeling community representative
of the 2000’s trend for blood cell theoretical study were the following. They were not really new, but
became real hits in this decade:
1- study of hematopoietic stem cells (HSC),
2- study of blood cancer in general and more particularly leukemia and its treatments.
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Let’s start with point 1. Even if assumed early in the 1900’s [208], their existence was indirectly
confirmed in the beginning of the 1960’s [50]. The 1980’s and 1990’s with the CD34 antigen allowed
biologist to target them in a more efficient way and so to be able to get better results in bone marrow
transplants. In the late 1990’s, 2000’s and even now, they are still the object of many experimental and
clinical studies linked to their development, life span, division rate, production rates, population number
in the bone marrow, plasticity to use them for the development of other organs, plasticity of progenitor
cells, turn over rate, ... All these questions have been the object of hundreds of models and thousands
of research papers, and even if their development started (from a modeling point of view), in the 1970’s,
an explosion of their studies emerged in the 2000’s with the first and second generations of theoreticians
working in this field. On the other hand, many HSC models were used as part of the models in term
of sources of cell production. Some models used HSC as an important part of the blood regulation,
specially in abnormal cases such as mutations leading to blood cancer. The main issue in that case is to
get as many reliable informations on this very particular cell population. Indeed, since many questions
remain open and mechanisms quite unclear, the edge between biological consistency and speculation can
be really thin in this topic. Some tried to get an estimate of their average number in the organism [107],
[108] predicted to be about 400 for an adult human. Other quantitative stem cell modeling have been
studied [250], [237], [194]. Some investigated their plasticity and self-organization in detail [190], [249],
[191], [238], [241]. It was also the opportunity to develop new delay models [87], [19], [23] with effect of
inducing agents [35] or using stochasticity [180]. An other approach was the use of asymmetric division
to keep self-renewing properties with differentiation at the same time [205], [251].
Study of HSC is closely related to our point 2. Indeed, since a link between leukemia and hematopoietic
stem cells showing the first cases of cancer stem cells had only been proven in the late 1990’s [66], it
appeared natural to see a great development of stem cell models in describing blood cancers in general
and chronic myelogenous leukemia (CML) in particular. This latter became a great hit during the years
2000’s. CML was then studied in a great variety of ways, from general models trying to describe the
regulating process of oscillating populations through many different feedback (mostly cause by stimulating
growth factors) in differential or structured differential equations, with or without delays [25], [26], [134],
[230], [201], [83], [84], [82], [112], [85], [231], [148], [215], [216], [240], [245], [138], [150], [3], [24], [113].
Two very interesting modeling topics related to this problem emerged during this decade:
i. modeling CML treatment with three different therapeutic strategies: the first and more popular
was Imatinib [247], [212], [214], [78], [159], the second strategy was to use the G-CSF growth hormone
(see introduction section 1)) [131], [132], [272] and the third one, with less scientific production (from a
modeling point of view) treatments with irradiations [184].
ii- A new problem rose the interest of modelers resistance to blood cancer treatments in general, with
applications to CML [244] but also acute myeloid leukemia (AML). This last one, was described either
by the study of transition states from CML to AML [112], [213] or by the AML problem only [183], [228],
[168], [17].
Other blood diseases were investigated in this period mostly in continuity of the previous decade such
as cyclic neutropenia [279], [154], [196], [56], [129], [80] or granulopoiesis in general [126], [267], [222],
[223].
Few important topics were studied but did not manage to become clear trends for the 2000’s: they were
for instance stressed erythropoiesis [91], [2], [49], [63], [14], [13], [16], [11], megakaryopoiesis [259], [36],
cell markers applied to blood cells [61], senescence [206], [116] or rare diseases such as beta-thalassemia
[236] to mention few of them.
Three topics however started to announce a new point of interest for the years early 2010’s: first
the implication of circadian rhythm [60], [77] and specially for cancer therapy [179], then techniques to
estimate parameter sensitivity [55], [2] and finally the study of cell molecular content [110], also quite
well investigated in the development of agent based models and cell fate studies.
Started in the 1990’s, this decade offered the opportunity give us a state of the art through several review
papers. Each review gave a good insight for different topics: dynamics of hematological diseases [131],
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population models structured by age and size [293], [292] as well as normal and pathological hematopoiesis
in general [6].
7. 2010’s: a third generation on its way
It is a little bit early to get an insight of the 2010’s. Most of the published works of the beginning of
this decade are in the continuity of the end of the 2000’s: cyclical neutropenia treatment by G-CSF [181],
[182], [71], [94], [301], CML study [139], [158], [224], [106], [48], [178], [257], AML study [275], [274], [47],
granulopoiesis [262], [263], HSC study [234], [207], [277], [33], [276], [281], [218], [5], [18], [136], [74] (with
two nice reviews dealing with treatments of hematological diseases [96]), [294], very few on erythropoiesis
[90], [261], [68] megakaryopoiesis [269], cell fate analysis [219]. There were mathematical development of
structured populations [70], [111], [67], [114] with delay equations [20], [88], [21], [15], [59], [4], [28], [27],
[32] (with a nice review paper dealing precisely on that topic [89]) or with asymmetric divisions [149].
It is interesting to point out some new or adapted mathematical techniques used to study differential-
difference new models [103], [7], [8], study spatial models [127] or investigate optimal control [115], [278].
Agent based models kept on being developed [162], [140] with complexity following the powerful im-
provements of computers (see an illustration of computing powerful options in Fig. 5).
Figure 5. An example red and white blood cell production in 3D [62].
There are actually several important things to note up to now.
1. The interest in modeling hematopoiesis, stem cell dynamics, blood disorders, treatments, resistance to
treatment or even blood transplant, never fade out. On the opposite, the seed planted half a century
ago became a real strong tree with many strong branches. Some still very young and developed only
in the end of the past decade, some a little weak, and others quite furnished. The outcome of this
remark is that a great numbers of students are being formed to this problem, and many of them follow
interdisciplinary formations, to become not only good in mathematics or biology, but to be experts
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in both of them. The next generation of researchers interested in this field should then appear to be
the strong links between the different communities and then propose even better solutions, strategies,
tools and techniques to solve problems, design experiments, collect clinical data in order to estimate
parameters accurately, propose optimal therapeutic protocols and develop new great models.
2. Numerous modeling attempts, fruitful results and long scientific discussions rose the interest of new
mathematicians on this topic (by the development of new analytical and numerical tools) but also
curiosity of biologists and clinicians not necessarily incline in exchanging ideas modelers, and more
specifically, people dealing with differential and partial differential equations to describe they work.
Many scientific success stories of some of these collaboration strengthened the idea that strong inter-
action between both of these communities was indeed a great idea. It became then easier and almost
natural to cooperate on many important clinical issues. One of the most recent examples could be
interactions with clinicians and mathematician to develop optimal strategies on the combinations of
different treatments at the same time to fight against leukemia, taking into account actions side effects
as well as organism circadian clock. Another example could be the study of the problem at different
levels (molecular, cellular, inter-cellular, organ) [102], [299] leading to the design of hybrid multi-scale
models [64], [128], [171] (see one example in Fig. 6).
Figure 6. The figure shows an example of hybrid modeling of hematopoiesis. Namely,
how tumor destroys erythroblastic islands which are the units of red blood cell production
in the bone marrow in mammals. Erythroblastic islands are composed of a macrophage
(big cells with black center and green annulus around) surrounded by erythroid progen-
itors (yellow cells) and reticulocytes (blue cells). Macrophages produce growth factors
that stimulate self-renewal of erythroid cells (green halo showing the concentration dis-
tribution and modeled with PDEs), reticulocytes produce Fas-ligand that determines
their differentiation and apoptosis (red halo). Other hematopoietic cells are shown in
violet. Tumor cells (light blue) expand and destroy the islands by direct mechanical
contact and biochemically by means of Fas-ligand (see [63]-[65], [68], [127], [128], [171]
for more details).
Finally one of the most difficult challenges for this decade will be to develop new experimental designs
and combine it to new mathematical tools and techniques to estimate sensitivity to several parameters
of a model but also to estimate their values in a very accurate way. One of the hot topics of the 2010’s
is also to get the estimates of parameters for some of the old or new models not only for the average
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population, but to get an individual answer corresponding to each specific profile of a person. This will
be then the time for development of “a` la carte” treatment following the most accurate and optimal
clinical protocols adapted the biological characteristics of every single patient.
Many challenges are thus opening the way to the new generations of interdisciplinary researchers. And
the past half century has only been the beginning.
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